/ /

All Latest Articles

The best is yet to comeWith the start of each new year also comes the hope for many innovations and advances. On top of that, I hope we can still make progress for our patients in our beloved field of ophthalmology.
Researchers reject vitamin D role in macular degeneration
Researchers reject vitamin D role in macular degenerationAnalyzing data from the European Eye Study, Gareth J. McKay, PhD, of Queen’s University in Belfast, United Kingdom, and colleagues in 7 countries in Europe found no meaningful association between serum 25-hydroxy vitamin D (25(OH)D) and AMD. They published the finding in Ophthalmology.
Evolutions in laser technologies making cataract surgery saferLaser techniques have fundamentally changed the cataract surgery landscape. New, versatile platforms have made surgery safer and provided superior clinical outcomes precisely, consistently and predictably.
Care lacking for diabetic eye diseases worldwideMillions of adults around the world run the risk of losing their eyesight because of inattention to complications of diabetes, according to a team of international researchers. “A quarter of people with diabetes surveyed are not discussing eye complications with their health care professional, with many presenting when vision problems have already occurred,” the report said.
Eyecare providers criticized for blue light claimsOptical services chains in the United Kingdom are misleading customers about filters to screen out blue light from electronic devices, according to the BBC. Boots Opticians and Vision Express both claim that the filters protect against retinal damage despite a lack of evidence, the news service said in a recent press release.
Mediterranean diet may protect against macular degeneration
Mediterranean diet may protect against macular degenerationThe Mediterranean diet reduces the risk of age-related macular degeneration (AMD), according to a study of two Portuguese populations.
Researchers make strides in amblyopiaAccumulating evidence suggests that multiple treatments can help people with amblyopia, according to a review of the literature.
Adalimumab effective but not a cure for uveitisAdalimumab (Humira, AbbVie), an immunosuppressive biologic therapy, improves the symptoms of noninfectious active uveitis, but causes some adverse events and does not cure the disease, researchers say.

Poll

View Results